Cervical cancer ranks as the fourth most prevalent cancer among women globally, and the second most widespread in India. It stems from infection with human papillomavirus (HPV), primarily transmitted through sexual activity, and begins in the cervix, the lower portion of the uterus.
Persistent infection with certain high-risk strains of HPV is responsible for over 95% of all cervical cancer cases.
Vaccination serves as an effective preventive measure against this virus. Administering the vaccine to girls aged 9-14, before sexual debut, proves highly effective, with over a 99% success rate in halting cervical cancer. Additionally, it offers protection against genital warts and certain other cancers.
HPV in India
With a vulnerable population of around 400 million women aged 15 and above, preventive measures are of utmost importance.
This holds particular significance for countries like India, which contribute to nearly a fifth of the global cervical cancer burden, reporting approximately 125,000 cases and 75,000 deaths annually.
To curb the incidence of cervical cancer, the government is expected to initiate an immunization campaign targeting Human Papillomavirus (HPV) in the second quarter of the year. Free vaccination will be provided to girls aged 9 to 14 years nationwide, divided into three phases spanning the next three years as part of the government's program. Once the catch-up phase is accomplished, the HPV vaccine will become a regular component of the government's immunization schedule for 9-year-old girls.
Priced between ₹200-400 per dose, it targets a minimum of four HPV strains. While vaccination is recommended for both genders, females face a heightened risk.
With a remarkable 97% effectiveness in preventing cervical cancer, the adoption of HPV vaccination programs has been widespread, with over 100 countries implementing them and witnessing a decline in cancer rates as a result.
Vaccines Available in India
Currently, different vaccines, like Cervarix and Gardasil, are available for cervical cancer prevention. India's own vaccine, Cervavac, will soon be released. It's affordable and requires two shots for ages 9-14, and three for ages 15-26.
The quadrivalent vaccines, from the Serum Institute of India, block the entry of four of the most prevalent HPV types: 16, 18, 6, and 11. This action helps prevent infections, genital warts, and ultimately, cancer. The domestically produced and more affordable Cervavac will be utilized in the government's campaign.
Hospitals/ platforms where you can get your dosage
If you do not qualify for the vaccine through the government's initiative or wish to receive it before the campaign begins, SII's Cervavac is accessible for purchase at ₹2,000 per dose. Your primary healthcare provider can administer the vaccine for you. You can also opt for these vaccinations online: https://proactiveforher.com/